Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/WA/Kennewick
Updated August 2026 from ClinicalTrials.gov

Paid Clinical Trials in Kennewick, WA

Studies commonly pay $75 to $4,500 per completed study

55 clinical trials are currently recruiting participants within 30 miles of Kennewick. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

55studies recruiting
4+research centers nearby
3condition categories
Live from the NIH registry

Studies recruiting near Kennewick right now

Top 25 of 55 recruiting studies, sorted by proximity — each links to its official registry page

Testing an Enhanced Digital Delivery Model for Inherited Cancer Genetic Testing in Young Adults With Cancer

Miscellaneous Neoplasm, Nos, Non-Neoplastic Condition, Nos N/A Interventional 535 participants sought
Kadlec Clinic Hematology and Oncology — Kennewick, Washington (2.0 mi) · Sponsor: Alliance for Clinical Trials in Oncology
See eligibility & contact on ClinicalTrials.gov (NCT07091617)

Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease

Stage III Colon Cancer Phase 2, Phase 3 Interventional 1,912 participants sought
Kadlec Clinic Hematology and Oncology — Kennewick, Washington (2.0 mi) · Sponsor: NRG Oncology
See eligibility & contact on ClinicalTrials.gov (NCT05174169)

Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Phase 3 Interventional 247 participants sought
Kadlec Clinic Hematology and Oncology — Kennewick, Washington (2.0 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT04269902)

Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response

Prostate Cancer (Adenocarcinoma) Phase 3 Interventional 830 participants sought
Kadlec Clinic Hematology and Oncology — Kennewick, Washington (2.0 mi) · Sponsor: Canadian Cancer Trials Group
See eligibility & contact on ClinicalTrials.gov (NCT06592924)

Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene Mutation

Prostate Adenocarcinoma, Stage IIIB Prostate Cancer AJCC v8 Phase 2 Interventional 44 participants sought
Kadlec Clinic Hematology and Oncology — Kennewick, Washington (2.0 mi) · Sponsor: SWOG Cancer Research Network
See eligibility & contact on ClinicalTrials.gov (NCT05806515)

Collection of Research Data and Samples From Patients Who Experience Immunotherapy Side Effects

Malignancy N/A Observational 240 participants sought
Kadlec Clinic Hematology and Oncology — Kennewick, Washington (2.0 mi) · Sponsor: Alliance for Clinical Trials in Oncology
See eligibility & contact on ClinicalTrials.gov (NCT04242095)

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis Phase 3 Interventional 1,264 participants sought
Kadlec Clinic Hematology and Oncology — Kennewick, Washington (2.0 mi) · Sponsor: Eli Lilly and Company
See eligibility & contact on ClinicalTrials.gov (NCT06119581)

Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial

Plasma Cell Myeloma, RISS Stage I Plasma Cell Myeloma Phase 3 Interventional 1,450 participants sought
Kadlec Clinic Hematology and Oncology — Kennewick, Washington (2.0 mi) · Sponsor: ECOG-ACRIN Cancer Research Group
See eligibility & contact on ClinicalTrials.gov (NCT04566328)

A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With Phesgo in Participants With PIK3CA-Mutated HER2-Positive Locally Advanced or Metastatic Breast Cancer

Metastatic Breast Cancer Phase 3 Interventional 230 participants sought
Kadlec Clinic Hematology and Oncology — Kennewick, Washington (2.0 mi) · Sponsor: Hoffmann-La Roche
See eligibility & contact on ClinicalTrials.gov (NCT05894239)

mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma

Advanced Esophageal Adenocarcinoma, Advanced Gastric Adenocarcinoma Phase 3 Interventional 382 participants sought
Kadlec Clinic Hematology and Oncology — Kennewick, Washington (2.0 mi) · Sponsor: Alliance for Clinical Trials in Oncology
See eligibility & contact on ClinicalTrials.gov (NCT05677490)

Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer

Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8 Phase 3 Interventional 3,680 participants sought
Kadlec Clinic Hematology and Oncology — Kennewick, Washington (2.0 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT06058377)

A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases

Acral Lentiginous Melanoma, Clinical Stage IV Cutaneous Melanoma AJCC v8 Phase 2 Interventional 112 participants sought
Kadlec Clinic Hematology and Oncology — Kennewick, Washington (2.0 mi) · Sponsor: SWOG Cancer Research Network
See eligibility & contact on ClinicalTrials.gov (NCT04511013)

Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers

Pancreatic Neoplasm N/A Observational 770 participants sought
Kadlec Clinic Hematology and Oncology — Kennewick, Washington (2.0 mi) · Sponsor: ECOG-ACRIN Cancer Research Group
See eligibility & contact on ClinicalTrials.gov (NCT04239573)

Ramucirumab and Paclitaxel or FOLFIRI in Advanced Small Bowel Cancers

Metastatic Small Intestinal Adenocarcinoma, Stage III Small Intestinal Adenocarcinoma AJCC v8 Phase 2 Interventional 94 participants sought
Kadlec Clinic Hematology and Oncology — Kennewick, Washington (2.0 mi) · Sponsor: SWOG Cancer Research Network
See eligibility & contact on ClinicalTrials.gov (NCT04205968)

Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging

Biochemically Recurrent Prostate Carcinoma, Metastatic Prostate Carcinoma Phase 3 Interventional 804 participants sought
Kadlec Clinic Hematology and Oncology — Kennewick, Washington (2.0 mi) · Sponsor: ECOG-ACRIN Cancer Research Group
See eligibility & contact on ClinicalTrials.gov (NCT04423211)

Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery

Head and Neck Squamous Cell Carcinoma, Hypopharyngeal Squamous Cell Carcinoma Phase 2 Interventional 189 participants sought
Kadlec Clinic Hematology and Oncology — Kennewick, Washington (2.0 mi) · Sponsor: ECOG-ACRIN Cancer Research Group
See eligibility & contact on ClinicalTrials.gov (NCT02734537)

S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity

Cardiotoxicity, HER2/Neu Positive Phase 3 Interventional 491 participants sought
Kadlec Clinic Hematology and Oncology — Kennewick, Washington (2.0 mi) · Sponsor: SWOG Cancer Research Network
See eligibility & contact on ClinicalTrials.gov (NCT03418961)

Evaluating the Impact of Social and Genetic Factors on Outcomes in Adolescent and Young Adult Cancer Survivors

Hodgkin Lymphoma, Non-Hodgkin Lymphoma N/A Observational 2,000 participants sought
Kadlec Clinic Hematology and Oncology — Kennewick, Washington (2.0 mi) · Sponsor: ECOG-ACRIN Cancer Research Group
See eligibility & contact on ClinicalTrials.gov (NCT06002828)

S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer

Anatomic Stage IV Breast Cancer AJCC v8, Estrogen Receptor Positive N/A Interventional 739 participants sought
Kadlec Clinic Hematology and Oncology — Kennewick, Washington (2.0 mi) · Sponsor: SWOG Cancer Research Network
See eligibility & contact on ClinicalTrials.gov (NCT03723928)

Study of Targeted Therapy vs. Chemotherapy in Patients With Thyroid Cancer

Refractory Differentiated Thyroid Gland Carcinoma Phase 3 Interventional 264 participants sought
Kadlec Clinic Hematology and Oncology — Kennewick, Washington (2.0 mi) · Sponsor: ECOG-ACRIN Cancer Research Group
See eligibility & contact on ClinicalTrials.gov (NCT06475989)

A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)

Melanoma Phase 3 Interventional 560 participants sought
Kadlec Clinic Hematology and Oncology — Kennewick, Washington (2.0 mi) · Sponsor: Regeneron Pharmaceuticals
See eligibility & contact on ClinicalTrials.gov (NCT06246916)

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

Multiple conditions Phase 2 Interventional 314 participants sought
Kadlec Clinic Hematology and Oncology — Kennewick, Washington (2.0 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT03866382)

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

Lung Non-Small Cell Carcinoma, Lung Non-Small Cell Squamous Carcinoma Phase 3 Interventional 1,210 participants sought
Kadlec Clinic Hematology and Oncology — Kennewick, Washington (2.0 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT04267848)
Actively enrolling

Studies you may be able to join near Kennewick

These studies are recruiting through partner research networks. We may be paid a referral fee if you complete their screening form — this never changes what you pay (nothing) or the compensation the study offers you.

Research study for alcohol-related liver damage

Enrolling US adults aged 18 to 70 with alcohol-induced liver damage and a history of heavy drinking. Not open to people with a recent stroke, heart attack, dialysis, or who take blood thinners.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility

Research study for bladder problems after spinal cord injury

This study is enrolling US adults aged 18 to 75 living with chronic involuntary bladder leakage caused by a spinal cord injury, for research including investigational gene therapy approaches. The study team confirms eligibility and any compensation before enrollment.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility
Google-rated

Top-rated research centers in Kennewick

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

Kadlec Clinic - Hematology and Oncology

★ 4.3
7360 W Deschutes Ave, Kennewick, WA 99336
(509) 942-2540
"My Dr is from Pakistan she is very brilliant and positive with patients very nice she is the future of this hospital we are really happy with her."
— Ron Patel, 5★

Tri-Cities Research District

3250 Port of Benton Blvd, Richland, WA 99354
(509) 375-0360

Kadlec Clinic - Rheumatology

★ 3.5
6710 W Okanogan Pl, Kennewick, WA 99336
(509) 942-2528
"I've only been here once after being on a 9 month waiting list.. I've seeing several Rheumatologest without finding one who could help me over ten ye…"
— D E W Adventures, 4★

Kadlec Neuroscience Center

★ 2.8
1100 Goethals Dr, Richland, WA 99352
"Dr. Spencer is different. He is a refreshing reminder that not all providers should be cold and clinical. He maintained being professional and was ve…"
— Vlad III, 5★

Clinical trials in Kennewick: what's recruiting

The Kennewick area currently has 55 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Kennewick, the most active research areas are:

  • Cancer & Oncology21 studies
  • Heart & Vascular1 studies
  • Liver & Kidney1 studies

Every listing shows the study phase, the recruiting site and its distance from Kennewick, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Kennewick

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Kennewick participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

Do I need to be sick to join a clinical trial in Kennewick?
No. Many studies recruit healthy volunteers, especially early-phase studies run at dedicated research centers. Others need participants diagnosed with a specific condition. Every trial lists its eligibility criteria — age range, condition, medications — and the study team screens you before enrollment.
Is compensation for clinical trials taxable?
In the U.S., clinical trial compensation is generally considered taxable income, and research sites may issue a 1099 form for payments above $600 in a year. Reimbursements for travel or meals are typically treated differently. Consult a tax professional for your situation.
What is the difference between a research center and a hospital study in Kennewick?
Dedicated research centers (listed on this page with their Google ratings) run studies as their core business — often healthy-volunteer and vaccine studies with structured compensation. Hospital and university studies tend to focus on patients with specific conditions. Both types are registered and IRB-supervised.
How often do new paid studies open in Kennewick?
Constantly — trials open and close enrollment every week. This page is refreshed weekly from the NIH registry. Join the email alert to be notified when a new study opens within 30 miles of Kennewick.
Can I be in more than one clinical trial at a time?
Generally no — most studies exclude participants currently enrolled in another trial, and paid Phase 1 studies enforce a washout period (often 30 days or more) between studies. Frequent healthy volunteers in Kennewick typically complete one or two studies per year.

Paid clinical trials near Kennewick

Other metros within reach

Spokane, WA291 Bellevue, WA1,520 Tacoma, WA1,464 Seattle, WA1,510 Vancouver, WA1,021 Marysville, WA200 Portland, OR1,021 Nampa, ID252

By condition

Eligibility and exclusions, condition by condition

Alcoholic Liver Disease in Kennewick Bladder Issues Due To Spinal Cord Injury in Kennewick All conditions

More of WA

Bellevue1,520 Seattle1,510 Bremerton1,481 Tacoma1,464 Vancouver1,021 Spokane291 Olympia234 Marysville200

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

By subscribing you agree to receive study alert emails. Unsubscribe anytime in one click.

Get free trial alerts